News & Insights
Stay Informed With Our Latest Updates
Explore our comprehensive collection of news and in-depth insights spanning practice areas, industries, and regions.
Firm News October 17, 2025
Gibson Dunn Advised BTG Pactual Strategic Capital and Legent Health on Sale of Legent Health to Hospital for Special Surgery and General Atlantic
Gibson Dunn advised BTG Pactual Strategic Capital and its portfolio company, Legent Health, on the sale of Legent Health to a partnership between Hospital for Special Surgery, the top-ranked orthopedic hospital in the U.S., and General Atlantic.
Firm News September 19, 2025
Gibson Dunn Advises 89bio on Its up to $3.5 Billion Sale to Roche Holdings
Gibson Dunn is advising 89bio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, on its up to $3.5 billion sale to Roche Holdings, Inc.
Accolades September 12, 2025
Lawdragon Names 66 Partners to 500 Leading Litigators in America Guide for 2026
Lawdragon has named 66 Gibson Dunn partners to its 500 Leading Litigators in America guide for 2026, which recognizes the outstanding advocates who “have made their mark representing clients in their most important courtroom, investigative, and administrative battles.”
Firm News August 21, 2025
Gibson Dunn Lawyers Appointed to ABA Antitrust Section Leadership Roles
Thirteen Gibson Dunn lawyers have been appointed to leadership roles in the American Bar Association Antitrust Section.
Firm News August 6, 2025
Gibson Dunn Advising Elo Touch Solutions on $1.3 Billion Sale to Zebra Technologies
Gibson Dunn is advising Elo Touch Solutions, Inc. on its $1.3 billion sale to Zebra Technologies Corporation.
Firm News July 9, 2025
Gibson Dunn Advises Merck on $10 Billion Verona Pharma Acquisition
Gibson Dunn is advising Merck & Co., Inc., one of the world’s largest pharmaceutical companies, on its $10 billion acquisition of Verona Pharma plc, a biopharmaceutical company focused on respiratory diseases.
Firm News July 3, 2025
Gibson Dunn Guides HPE to Favorable DOJ Settlement in Challenge to HPE-Juniper Merger
Gibson Dunn successfully represented Hewlett Packard Enterprise (HPE) in securing a settlement with the U.S. Department of Justice (DOJ) that cleared the way for HPE’s $14 billion acquisition of Juniper Networks.
Firm News June 23, 2025
Gibson Dunn Representing C&S Wholesale Grocers in $1.77 Billion Acquisition of SpartanNash
Gibson Dunn is representing C&S Wholesale Grocers, LLC in its $1.77 billion acquisition of the SpartanNash Company